Viropharma Inc Asset Turnover Ratio (VPHM), as of third quarter 2013, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Viropharma Inc  (VPHM)
 

Viropharma Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Viropharma Inc asset turnover ratio, the ability of Viropharma Inc's assets to generate revenue in the third quarter 2013, increased sequentially to 0.4 in the third quarter (Sep 30 2013), yet the ratio remained below the average, as VPHM's position remain challenging.

Within sector 7 more businesses have achieved higher asset turnover ratio. While Asset turnover ratio total ranking has improved so far during the III Quarter 2013, to 898, from total ranking in the second quarter 2013 at 962.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

VPHM Asset Turnover Ratio (Sep 30 2013)
III. Quarter		 (Jun 30 2013)
II. Quarter		 (Mar 31 2013)
I. Quarter		 (Dec 31 2012)
IV. Quarter		 (Sep 30 2012)
III. Quarter
Y / Y Asset Change -8.48 % -20.57 % -17.58 % -7.48 % -0.39 %
Y / Y Revenue Change 24.24 % 9.59 % - - -
Asset Turnover Ratio (TTM) 0.4 0.37 - 0.33 0.14
VPHM's Total Ranking # 898 # 962 # 0 # 0 #
Seq. Asset Change 2.08 % 2.53 % -14.24 % 1.97 % -11.41 %
Seq. Revenue Change 9.02 % - - 166.24 % -3.84 %



Asset Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 8
Healthcare Sector # 50
Overall Market # 898

Asset Turnover Ratio Statistics
High Average Low
9.06 8.33 6.93
(Sep 30 2013)   (Jun 30 2012)




VPHM Company Profile • Back to VPHM Efficiency Comparisons • Compare VPHM Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Sep 30 2013, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Sep 30 2013 Assets at quarter ending Sep 30 2013
Luna Innovations Inc  1.11 $ 23.953  Millions$ 21.590  Millions
Idexx Laboratories Inc  1.10 $ 1,531.302  Millions$ 1,395.807  Millions
Tenet Healthcare Corp  1.09 $ 9,548.000  Millions$ 8,728.500  Millions
Lakeland Industries Inc   1.09 $ 92.562  Millions$ 85.061  Millions
Option Care Health Inc   1.05 $ 779.421  Millions$ 745.276  Millions
Pro dex Inc   1.04 $ 11.343  Millions$ 10.905  Millions
Gadsden Properties, Inc.  1.02 $ 215.965  Millions$ 210.836  Millions
Msa Safety Inc  1.02 $ 1,158.888  Millions$ 1,139.049  Millions
Bohai Pharmaceuticals Group, Inc.  1.02 $ 167.333  Millions$ 164.564  Millions
Cryoport inc   1.01 $ 1.743  Millions$ 1.728  Millions
Carlisle Companies Incorporated  1.00 $ 3,505.500  Millions$ 3,493.725  Millions
Xtant Medical Holdings Inc   0.99 $ 32.937  Millions$ 33.350  Millions
Abiomed Inc   0.98 $ 168.939  Millions$ 171.623  Millions
Bruker Corporation  0.97 $ 1,804.600  Millions$ 1,851.575  Millions
Pressure Biosciences Inc   0.97 $ 1.365  Millions$ 1.406  Millions
Lemaitre Vascular Inc   0.96 $ 61.434  Millions$ 64.144  Millions
Lannett Company Inc  0.95 $ 161.589  Millions$ 170.370  Millions
Varian Medical Systems Inc   0.94 $ 2,942.897  Millions$ 3,132.043  Millions
Abaxis Inc  0.93 $ 188.773  Millions$ 202.269  Millions
Thermogenesis Holdings Inc   0.93 $ 17.485  Millions$ 18.761  Millions
Cantel Medical Corp   0.92 $ 443.617  Millions$ 482.428  Millions
Encompass Health Corporation  0.91 $ 2,254.000  Millions$ 2,471.075  Millions
3m Company  0.91 $ 30,689.000  Millions$ 33,909.750  Millions
Intelgenx Technologies Corp   0.90 $ 1.752  Millions$ 1.944  Millions
Tivity Health Inc   0.90 $ 669.229  Millions$ 742.611  Millions
Myriad Genetics Inc   0.90 $ 682.195  Millions$ 758.063  Millions
Insulet Corporation  0.90 $ 236.379  Millions$ 263.652  Millions
Abbvie Inc   0.89 $ 24,516.000  Millions$ 27,584.750  Millions
Champions Oncology Inc   0.89 $ 10.162  Millions$ 11.459  Millions
Inotiv Inc   0.89 $ 22.068  Millions$ 24.907  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.